Translate
About
Abbott Laboratories (NYSE:ABT) — investor relations, events, news, and company updates on 6ix.
Latest News
Today
Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform
Apr 25 2026
Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026
Apr 23 2026
Catheters Market Report 2025-2030, Profiles and Strategy Analysis of Leading Players - Abbott Laboratories, Boston Scientific, Medtronic, Terumo, and B. Braun
Apr 17 2026
New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test
Apr 16 2026
Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences
Financials
Revenue
$44.33 B
Market Cap
$178.76 B
P/E Ratio
27.65
EPS
3.72
Dividend Yield
2.34%